TotalMarketCap

Alaunos Therapeutics

TCRTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$7.514 M

$1.82 +1.11%

Close of 6 Nov 2026

As of 6 Nov 2026, Alaunos Therapeutics (TCRT) has a market capitalization of $7.51M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$5.00K

#3609 by revenue

Earnings

-$4.18M

Loss-making

Shares outstanding

2,540,480

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #425CalciMedicaCALC$8.71M
  2. #426Lantern PharmaLTRN$8.09M
  3. #427Alaunos TherapeuticsTCRT$7.51M
  4. #428Tempest TherapeuticsTPST$7.51M
  5. #429Theriva BiologicsTOVX$7.43M

What if Alaunos Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$6,839,568

Per share 3,758,004× higher

Bitcoin $1.53T

$370,077.10

Per share 203,339× higher

Apple $5.02T

$1,214,929

Per share 667,543× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Alaunos Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.